All News

No-Shave November offers an opportunity for cancer awareness and fundraising. Contemplating whether to join in or not can bring back memories of when there was no choice but to go bald instead of letting our hair go wild.

A newly studied blood test could be the answer to a serious question: How can a woman tell if she has ovarian cancer in its earliest stage?

When our bodies have experienced trauma, it is so easy to live in fear of what else may go wrong. But accepting that we don't know what will happen to us also means accepting that the worst is not always inevitable. Sometimes, despite our fears, we still thrive, and that is a reason to recognize that even if you've suffered, you can still be OK.

It was a hard call to make. It felt like choosing to step into the mud—again. Revisit cancer? Seriously? Why?

One of our valued community members, Jen Sotham, passed away on Nov. 9. Jen was diagnosed with metastatic melanoma in 2014, but that did not prevent her from living out her dreams and having her voice heard through film, blogging, a TED talk and contributing to CURE® — both in print and on the web.

People with cancer have to gear up for the emotional and mental workout of dealing with insurance. Here are some tips for coping.

Treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) improved response rates in patients with melanoma, but not without some severe side effects.

There has been a “renaissance” in the treatment strategies of patients with non-small cell lung cancer (NSCLC) who have EGFR-mutation–positive disease, Edward S. Kim, M.D.

Two-time cancer survivor struggles with a different loss than cancer this holiday season.

Marina C. Garassino, M.D., talks about exciting advances in the field of lung cancer.

Are you trying to get ready for the holidays in addition to being newly diagnosed with cancer, receiving active treatment or coping with survivorship? It’s not an easy task.

A patient with metastatic breast cancer discusses what helps her find comfort.

Many patients who completed the survey felt maintenance therapy would help them buy time.

Clinical trials of combination immunotherapy treatments are showing impressive overall survival rates.

Sprycel (dasatinib), an oral medication that helps reduce the production of damaged white blood cells, has been approved by the Food and Drug Administration for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.

A two-time cancer survivor shares strategies that have helped her over the years with healthy eating habits and movement.